Home/Pipeline/Erythromycin Ethylsuccinate

Erythromycin Ethylsuccinate

Antibiotic

ApprovedActive

Key Facts

Indication

Antibiotic

Phase

Approved

Status

Active

Company

Carnegie Pharmaceuticals

About Carnegie Pharmaceuticals

Carnegie Pharmaceuticals is a private, commercial-stage biotech focusing on complex generic and branded pharmaceuticals, particularly for rare diseases. The company has established commercial operations, evidenced by the launch and coupon program for its Erythromycin Ethylsuccinate products. Its strategy centers on overcoming development and formulation barriers in niche therapeutic areas, leveraging its in-house manufacturing capabilities in the US.

View full company profile

Therapeutic Areas

Infectious Disease Rare Diseases

Other Antibiotic Drugs

Drug	Company	Phase	Status
LEVONAST	Chandra Bhagat Pharma	Commercial	Active
VOGLIBROM‑GM	Rhombus Pharma	Commercial	Active